Register Login
Register to leave comments
  • News bot March 11, 2026, 12:36 p.m.

    📋 ENZON PHARMACEUTICALS, INC. (ENZN) - Regulatory Update

    Filing Date: 2026-03-11

    Accepted: 2026-03-11 08:34:49

    Event Type: Regulatory Update

    Event Details:

    ENZON PHARMACEUTICALS, INC. (ENZN) Announces Regulatory Update ENZON PHARMACEUTICALS, INC. (ENZN) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (ENZON PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    PEG-paclitaxel DRUG Phase PHASE1 Neoplasm ClinicalTrials.gov
    EZN-2208 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Amphotericin B DRUG Phase PHASE3 Lung Transplantation ClinicalTrials.gov
    Oncaspar & Gemzar; advanced and/or solid tumors and lymphoma DRUG Phase PHASE1 Tumors ClinicalTrials.gov
    Intravenous recombinant human mannose binding lectin DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    recombinant human mannose-binding lectin BIOLOGICAL Phase PHASE1 Fever, Sweats, and Hot Flashes ClinicalTrials.gov
    Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL) DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Intravenous EZN-2968 (anti-HIF-1α LNA AS-ODN) DRUG Phase PHASE1 Carcinoma ClinicalTrials.gov
    EZN-2208, Cetuximab and Irinotecan DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Pegamotecan DRUG Phase PHASE2 Sarcoma, Soft Tissue ClinicalTrials.gov
    Pegaspargase DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Ara-C DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Methotrexate (MTX) DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    G-CSF DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Decadron DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Doxorubicin DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Vincristine DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Cyclophosphamide (CTX) DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    EZN-4176 DRUG Phase PHASE1 Prostatic Neoplasm ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE1 Neoplastic Meningitis ClinicalTrials.gov
    DepoCyt DRUG Phase PHASE1 Neoplastic Meningitis ClinicalTrials.gov
    cytarabine liposome injection DRUG Phase PHASE2 Neoplastic Meningitis ClinicalTrials.gov
    ABLC DRUG Phase PHASE3 Invasive Fungal Infections ClinicalTrials.gov
    Posaconazole DRUG Phase PHASE3 Invasive Fungal Infections ClinicalTrials.gov
    Placebo Capsule OTHER Phase PHASE1 Toxicity ClinicalTrials.gov
    N-Methanocarbathymidine DRUG Phase PHASE1 Toxicity ClinicalTrials.gov
    6 Mercaptopurine DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Clofarabine DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Imatinib DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Methotrexate DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    PEG-asparaginase DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Prednisone DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib DRUG Phase PHASE3 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine DRUG Phase PHASE3 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    ZN-e4 DRUG Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    Hydrocortisone DRUG Phase PHASE1 Lymphoblastic Leukemia, Acute ClinicalTrials.gov
    EZN-3042 DRUG Phase PHASE1 Lymphoblastic Leukemia, Acute ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ENZON PHARMACEUTICALS, INC.
    • Ticker Symbol: ENZN

Search

News categories